Biotech & Life Science
The latest biotechnology and life science news.
Manufacturing accounts for 440,000 North Carolina jobs today; in rural parts of North Carolina, manufacturing accounts for 14 percent of total employment and $9.3 billion in annual wages
October 24, 2012
GlaxoSmithKline is launching a recycling program for respiratory inhalers for the first time, The Raleigh-Durham area is among 31 metro areas where the program is being launched.
October 22, 2012
The breakthrough in stem cell research by a Nobel Prize winner has enabled GSK to create heart-muscle stem cells that may be used to test compounds for cardiovascular safety, says Jason Gardner, head of Glaxo's early-stage regenerative medicine research.
September 29, 2012
Patients taking Glaxo's dabrafenib and trametinib together delayed tumors from progressing for 9.4 months, compared with 5.8 months for patients taking dabrafenib alone, according to the study of 162 patients. The trial was part of the second of three phases of human testing usually required by regulators.
July 22, 2012
As a global AIDS conference opens in Washington, activists say the U.S. is seeking to shift burden of AIDS fight at exactly the wrong time with big progress being made against the deadly disease.
Updated July 16, 2012
GlaxoSmithKline increased its offer to buy Human Genome Sciences in a hostile takeover bid to $14.25 from $13 per share.
Updated July 13, 2012
Nearly 60 individual investors flock to support Sprout Pharmaceuticals, which is working toward FDA approval for a compound developed to treat hypoactive sexual desire disorder. It's a form of female sexual dysfunction that essentially means low sexual desire.
Updated July 2, 2012
GlaxoSmithKline Plc agreed to plead guilty and pay a $3 billion settlement to resolve criminal and civil charges linked to the company's illegal promotion of prescription drugs and its failure to report safety data.
July 2, 2012
The drug to treat patients with chronic obstructive pulmonary disease under development could mean $3.5 billion or more a year in sales for Glaxo and replace its best-selling Advair, analysts say.
Updated June 18, 2012
The justices, voting 5-4 in a case involving a GlaxoSmithKline unit, said pharmaceutical salespeople are exempt from a federal wage-and-hour law.
Updated June 4, 2012
The two gene-blocking drugs top chemotherapy results in clinical trials. If approved, they could produce more than $2 billion in revenue by 2020.
April 30, 2012
Researchers at the UNC-CH Nutrition Research Institute have linked a gene that could be a genetic cause for some cases of male infertility.
April 30, 2012
Millennium Laboratory, which is based in North Raleigh, is being acquired by another company. The deal is expected to close this week. As a result 140 people are being let go, the company says.
Updated April 23, 2012
The founder of the world's largest life science services firm says time was right for a change. However, he will remain chairman of the board. Gillings will be replaced as CEO by Accenture executive Tom Pike as of April 30.
Updated January 11, 2012
The Chapel Hill-based health insurer and BCBS of Kansas City have formed a company called Topaz Shared Services. Both firms are recruiting current employees to fill 40 jobs. It's "too soon to tell" if the move will create job cuts, a BCBSNC spokesperson says.